ArticleOPEN ACCESS

Erratum: Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus⇓unrelated head and neck cancer: A multicenter, phase II trial (CLINICAL CANCER RESEARCH2020;26:5140–52 DOI: 10.1158/1078-0432.CCR-20-1695)

Clinical Cancer Research
DOI: 10.1158/1078-0432.CCR-20-4484
8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original version of this article (1), Fig. 4A and B were duplicated. Figure 4B has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Cite

CITATION STYLE

APA

Uppaluri, R., Campbell, K. M., Egloff, A. M., Zolkind, P., Skidmore, Z. L., Nussenbaum, B., … Adkins, D. R. (2021, January 1). Erratum: Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus⇓unrelated head and neck cancer: A multicenter, phase II trial (CLINICAL CANCER RESEARCH2020;26:5140–52 DOI: 10.1158/1078-0432.CCR-20-1695). Clinical Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/1078-0432.CCR-20-4484

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free